Physician profile
Harshpal Singh
NPI 1437317567
$677,492.77
in general payments reported to CMS, 2019-2025
33 companies · $44K in 2025
The $44K reported for 2025 was more than what 94% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34K · 2020: $6,767 · 2021: $26K · 2022: $32K · 2023: $509K · 2024: $27K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $492K · Royalty Or License: $38K · Consulting Fee: $28K · Food and Beverage: $12K · Travel and Lodging: $9,259 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $491,997.79 |
| Royalty Or License | $37,787.14 |
| Consulting Fee | $28,125.00 |
| Food and Beverage | $11,812.30 |
| Travel and Lodging | $9,259.05 |
| Education | $129.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $491,997.79 | 2023 | |
| Globus Medical, INC. | $73,981.01 | 2019-2025 | Modulus, Elsa, Elsa, Elsa Al/Atp |
| Nuvasive, INC. | $41,781.82 | 2019-2023 | Xlif, Alif, Acp |
| Alphatec Spine, INC | $32,390.62 | 2023-2025 | Other - Miscellaneous, Lif, Invictus Mis |
| Bioventus LLC | $13,280.51 | 2019-2022 | |
| Medtronic, INC. | $12,054.52 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Corelink, LLC | $4,127.01 | 2019-2022 | |
| Medical Device Business Services, INC. | $879.40 | 2024 | Teligen |
| Medtronic USA, INC. | $851.23 | 2019-2020 | |
| Zimvie INC. | $780.68 | 2023-2024 | |
| Si-Bone, INC. | $609.33 | 2020-2023 | |
| Royal Biologics, INC. | $609.12 | 2024-2025 | |
| Depuy Synthes Sales INC. | $488.09 | 2019-2024 | Teligen, Conduit |
| Integrity Implants INC. Dba Accelus | $440.39 | 2023 | |
| 4web, INC. | $432.40 | 2024 | Spine Truss System |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $407.79 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Stryker Corporation | $283.18 | 2019-2024 | Cascadia Interbody System |
| Carlsmed, INC. | $275.85 | 2024 | Aprevo |
| Highridge Medical LLC | $257.00 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Curiteva, INC. | $249.05 | 2024 | |
| Nevro Corp. | $235.15 | 2022-2023 | Senza |
| Augmedics INC. | $231.00 | 2024 | Xvision |
| 7d Surgical INC. | $222.80 | 2020 | |
| Providence Medical Technology, INC. | $149.75 | 2022 | |
| Baxter Healthcare | $142.10 | 2019-2020 | |
| Ossdsign USA Incorporated | $101.60 | 2024 | |
| Janssen Pharmaceuticals, INC | $93.13 | 2022-2025 | Spravato |
| Djo, LLC | $37.68 | 2024 | Cmf |
| Foundation Fusion Solutions, LLC | $26.77 | 2025 | |
| Abbott Laboratories | $21.80 | 2025 | Eterna |
| Saluda Medical Americas, INC. | $20.10 | 2023 | Evoke Scs |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.18 | 2025 | Caplyta |
| Vertex Pharmaceuticals Incorporated | $15.92 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harshpal Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.